Trade Longeveron Inc. - LGVN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.83 |
| Open | 1.77 |
| 1-Year Change | -6.84% |
| Day's Range | 1.77 - 1.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | 1.83 | -0.02 | -1.08% | 1.85 | 1.87 | 1.78 |
| Nov 20, 2024 | 1.84 | 0.02 | 1.10% | 1.82 | 1.88 | 1.75 |
| Nov 19, 2024 | 1.83 | -0.06 | -3.17% | 1.89 | 1.89 | 1.71 |
| Nov 18, 2024 | 1.91 | -0.06 | -3.05% | 1.97 | 1.97 | 1.85 |
| Nov 15, 2024 | 1.95 | -0.04 | -2.01% | 1.99 | 2.02 | 1.84 |
| Nov 14, 2024 | 2.06 | -0.02 | -0.96% | 2.08 | 2.10 | 1.97 |
| Nov 13, 2024 | 2.10 | -0.04 | -1.87% | 2.14 | 2.22 | 2.04 |
| Nov 12, 2024 | 2.28 | 0.09 | 4.11% | 2.19 | 2.29 | 2.05 |
| Nov 11, 2024 | 2.16 | 0.02 | 0.93% | 2.14 | 2.20 | 2.07 |
| Nov 8, 2024 | 2.17 | -0.02 | -0.91% | 2.19 | 2.22 | 2.12 |
| Nov 7, 2024 | 2.18 | 0.06 | 2.83% | 2.12 | 2.24 | 2.11 |
| Nov 6, 2024 | 2.13 | -0.07 | -3.18% | 2.20 | 2.24 | 2.11 |
| Nov 5, 2024 | 2.22 | 0.13 | 6.22% | 2.09 | 2.24 | 2.09 |
| Nov 4, 2024 | 2.14 | 0.13 | 6.47% | 2.01 | 2.19 | 1.89 |
| Nov 1, 2024 | 2.02 | -0.02 | -0.98% | 2.04 | 2.10 | 2.01 |
| Oct 31, 2024 | 2.07 | -0.04 | -1.90% | 2.11 | 2.14 | 2.03 |
| Oct 30, 2024 | 2.14 | 0.02 | 0.94% | 2.12 | 2.19 | 2.03 |
| Oct 29, 2024 | 2.17 | 0.12 | 5.85% | 2.05 | 2.21 | 2.04 |
| Oct 28, 2024 | 2.15 | -0.05 | -2.27% | 2.20 | 2.46 | 2.09 |
| Oct 25, 2024 | 2.18 | 0.09 | 4.31% | 2.09 | 2.19 | 2.06 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Longeveron Inc Company profile
Longeveron Inc. (LGVN) is a clinical-stage biotechnology company. Its lead drug component and cellular therapies address ageing and other life-threatening conditions. Founded in 2014, Longeveron is headquartered in Miami, US.
The biotech firm’s leading product Lomecel-B is derived from culture-expanded medicinal signalling cells (MSCs). The cells were sourced from young healthy adult donors’ - aged 18 to 45 - bone marrow to treat ageing-related diseases as they promote cell and tissue repair, organ maintenance and immune system function.
As of June 2022, the company is conducting Phase 2 clinical trials in hypoplastic left heart syndrome (HLHS) and Alzheimer’s disease. It has received orphan drug and rare paediatric disease designations from the US Food and Drug Administration (FDA).
Longeveron is also conducting Phase 1 and 2 clinical trials for ageing frailty, metabolic syndrome and acute respiratory distress syndrome due to Covid-19 or influenza.
Longeveron’s programmes have been awarded grant funding of more than $16.2m from various organisations, including the National Institute on Ageing (NIA), National Heart Lung and Blood Institute (NHLBI), the Alzheimer’s Association and the Maryland Stem Cell Research Fund (MSCRF).
Longeveron Inc. stock started trading on the NASDAQ stock exchange in February 2021 under the ticker symbol LGVN.
You can follow live LGVN stock price movements and price history and keep up with the latest LGVN share value at Capital.com
| Industry: | Biotechnology & Medical Research (NEC) |
1951 NW 7th Ave
Ste 520
MIAMI
FLORIDA 33136
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com